Literature DB >> 7709864

Testing strategies to increase use of chloroquine chemoprophylaxis during pregnancy in Malaŵi.

D L Helitzer-Allen1, A Macheso, J Wirima, C Kendall.   

Abstract

The widespread problem of low and non-compliance to antimalarial chemoprophylaxis during pregnancy demands that attention be focused on alternative approaches to programming, product acceptability and demand for preventive services. This study describes the testing of three interventions to determine their effect on use of chloroquine (currently the most widely used drug for chemoprophylaxis) during pregnancy. The strategies evolved from community-based formative research undertaken to learn about the local concept of malaria and issues surrounding malaria prevention and treatment during pregnancy. The resulting interventions were tested in four clinics, and included a change in the health education message given during antenatal sessions, distribution of a sugar-coated chloroquine tablet, and an intervention combining the two strategies. The results showed a 45% increase in chloroquine use when the health education message was changed, and a 64% increase when the product was changed. High use levels were maintained with the combined intervention; an additive effect was seen. The study shows that improving the product was the most important factor in increasing the use of the program, and that changing the health education message can also make an impact on use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7709864     DOI: 10.1016/0001-706x(94)90019-1

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

1.  Multisite formative assessment for the Pathways study to prevent obesity in American Indian schoolchildren.

Authors:  J Gittelsohn; M Evans; M Story; S M Davis; L Metcalfe; D L Helitzer; T E Clay
Journal:  Am J Clin Nutr       Date:  1999-04       Impact factor: 7.045

Review 2.  Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.

Authors:  Denitsa Radeva-Petrova; Kassoum Kayentao; Feiko O ter Kuile; David Sinclair; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2014-10-10

Review 3.  Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

Authors:  R Matthew Chico; Daniel Chandramohan
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-07-07       Impact factor: 4.481

4.  "It is good for my family's health and cooks food in a way that my heart loves": qualitative findings and implications for scaling up an improved cookstove project in rural Kenya.

Authors:  Bobbie Person; Jennifer D Loo; Mercy Owuor; Lorraine Ogange; Maria Elena D Jefferds; Adam L Cohen
Journal:  Int J Environ Res Public Health       Date:  2012-04-30       Impact factor: 3.390

5.  Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.

Authors:  Aurélia Souares; Patricia Moulin; Sophie Sarrassat; Marie-Paule Carlotti; Richard Lalou; Jean-Yves Le Hesran
Journal:  Malar J       Date:  2009-11-17       Impact factor: 2.979

Review 6.  Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.

Authors:  R Matthew Chico; Rudiger Pittrof; Brian Greenwood; Daniel Chandramohan
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

Review 7.  The role of health systems and policy in producing behavior and social change to enhance child survival and development in low- and middle-income countries: an examination of the evidence.

Authors:  Luis F Vélez; Mary Sanitato; Donna Barry; Martin Alilio; Franklin Apfel; Gloria Coe; Amparo Garcia; Michelle Kaufman; Jonathan Klein; Vesna Kutlesic; Lisa Meadowcroft; Wendy Nilsen; Gael O'Sullivan; Stefan Peterson; Daniel Raiten; Susan Vorkoper
Journal:  J Health Commun       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.